PTH1R and prostate cancer: In vitro studies have shown that synthetic PTHrP (1–34) peptide or overexpression of full-length Pth1r significantly induces cancer cell proliferation and promotes survival in various types of cancer, including prostate cancer [48,49,50], renal carcinoma [78], and breast cancer [85].